ThePrint ·
Kapiva Partners with Central Council for Research in Ayurvedic Sciences (CCRAS) to Commercialise Clinically Evaluated Ayurvedic Formulations
New Delhi [India], September 17: Kapiva, one of India’s most trusted science-backed Ayurvedic brands, has entered into a strategic technology transfer and commercialisation alliance with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, Government of India, to bring clinically evaluated Ayurvedic technologies and formulations to a wider consumer base.
Under the agreement, CCRAS will provide Kapiva with access to its proprietary Ayurvedic formulations, scientific intellectual property, standardisation and manufacturing protocols, and supporting pre-clinical and clinical data. The partnership will initially cover 10 products across health areas including pain, stress, metabolic health, sleep, liver health and respiratory health.
Kapiva will lead the next stage of product development and commercialisation, including adaptation into modern consumer-friendly formats, manufacturing at scale, branding and nationwide distribution. The brand will undertake formulation adaptation and product optimization across areas such as taste, shelf-life, delivery formats, and consumer convenience. Where a dosage form is changed, appropriate dose-equivalence studies will be conducted.
